ArticleOncology letters2021

Application of a small molecule inhibitor screen approach to identify CXCR4 downstream signaling pathways that promote a mesenchymal and fulvestrant-resistant phenotype in breast cancer cells.

Margarite D Matossian et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.